Telemetric Regenerative Bandage for Accelerating Wound Healing
用于加速伤口愈合的遥测再生绷带
基本信息
- 批准号:10346507
- 负责人:
- 金额:$ 64.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AcrylamidesAddressAdhesionsAmputationAnimal ModelAnimalsAntioxidantsAttenuatedBacterial InfectionsBandageBiocompatible MaterialsBlood CirculationBody TemperatureCaringCellsChronicCitratesClinicClinicalComplications of Diabetes MellitusCopperDermalDevelopmentDevicesDiabetes MellitusDiabetic Foot UlcerDiabetic mouseDigit structureDiseaseEndothelial CellsEngineeringExposure toFamily suidaeFeedbackFibroblastsFree RadicalsGelGoalsHealthHealthcareHigh PrevalenceHospitalsHumanImmobilizationImpaired healingImpaired wound healingImpairmentImplantIn VitroIncidenceInfectionInflammationLamininLeadLeftLimb structureLocationLower ExtremityMeasuresMedical DeviceMetabolic syndromeMetalsMiniature SwineMonitorOperative Surgical ProceduresOxidative StressPatient-Focused OutcomesPatientsPeptidesPersonal SatisfactionPhysiciansPolyethylene GlycolsPopulationPositioning AttributePrevalenceProcessPropertyResearchResearch PersonnelSafetySepsisShapesSkinSkin wound healingSocietiesSpecific qualifier valueSterile coveringsStretchingSystemTelemetryTemperatureTestingThickTimeTissuesVascularizationWireless TechnologyWorkWound Infectionangiogenesisbasebiomaterial compatibilityblood perfusionclinically relevantdb/db mousediabetes amputationdiabeticdiabetic ulcereffective therapyflexibilityhealinghealth care deliveryhealth care disparityhuman diseaseimprovedinnovationkeratinocytelimb amputationmacromoleculemicrosensormigrationmouse modelnanoparticlenanoparticle deliveryneovascularizationnon-healing woundsnoveloutcome predictionporcine modelpreventregenerativeresearch clinical testingscaffoldsensorskin woundtherapy outcometissue regenerationtoolwoundwound bedwound carewound closurewound dressingwound healing
项目摘要
Summary
Diabetic foot ulcers (DFUs) are a major complication of diabetes. These sores, if left untreated, can become
infected and become a serious threat to the patient’s well being. Although the field of wound care management
is well established, the effective treatment of chronic DFUs remains a challenge. The primary goal in the
treatment of DFUs is for the wound to close as soon as possible and to do so in a durable way. However,
prolonged inflammation, oxidative tissue damage, and impaired blood circulation in diabetic wounds delay the
wound healing process, resulting in open, non-healing wounds that often lead to limb amputations. This proposal
will address these problems by developing a versatile wound dressing that restores normal wound healing rates
by reducing free radicals in the wound, providing a native-like scaffold for the cells to divide and migrate, and
enhancing vascularization in the wound. Another problem is the inability to monitor the wound in real time after
the patient leaves the hospital, leading to digit or limb amputations. We will address this problem by developing
a wireless system that can monitor the temperature and pH of the wound in real time, parameters that have been
shown to be indicators of infection. Therefore, the overall goal of this proposal is to develop a shape-
conforming antioxidant dressing that upon exposure to body temperature transforms into a gel that
promotes new tissue formation in diabetic wounds and a feedback system that involves tissue
conforming sensors to monitor bacterial infection and/or lack of healing. Toward this goal, we have
developed a novel macromolecule - poly (polyethylene glycol citrate-co-N isopropyl acrylamide) - that
incorporates a laminin-derived peptide. This material, referred to as PPCN-A5G81, supports tissue regeneration
and can conform to the unique shape and depth of a wound. As for wireless monitoring of the wound, we
pioneered the development of flexible, stretchable electronic sensors that can be integrated with human skin or
implanted into the body for continuous, non-invasive health monitoring and treatment of disease. We hypothesize
that: 1) incorporating immobilized Cu2+ into PPCN-A5G81 will confer vasculoinductive properties that significantly
increase PPCN-A5G81’s ability to restore normal healing rates of full thickness dermal wounds in diabetic mouse
and swine models; and 2) conforming temperature and pH sensors are safe and can remotely provide real time
information regarding blood perfusion and infection in dermal wounds in diabetic animals. The specific aims of
this proposal are to: 1) fabricate a PPCN-based regenerative dressing with vasculoinductive, dermoconductive,
and dermoinductive properties and investigate its safety and efficacy for healing full thickness wounds in diabetic
mice and diabetic pigs with metabolic syndrome; and 2) fabricate and characterize telemetric wound feedback
tissue-conforming sensors capable of measuring temperature and pH in infected and non-infected diabetic
dermal wounds. Results from this research will contribute to the development of innovative clinical products that
reduce amputation rates and improve patient outcome.
摘要
糖尿病足溃疡(DFU)是糖尿病的主要并发症。这些溃疡,如果不治疗,可能会变成
感染并成为对患者健康的严重威胁。尽管伤口护理管理领域
尽管慢性DFU的有效治疗已经确立,但仍然是一项挑战。的主要目标是
DFU的治疗是为了伤口尽快愈合,并以持久的方式这样做。然而,
糖尿病创面的长期炎症、氧化组织损伤和血液循环障碍延迟了
伤口愈合过程,导致开放的、无法愈合的伤口,常常导致截肢。这项建议
将通过开发一种多功能伤口敷料来解决这些问题,这种敷料可以恢复正常的伤口愈合率
通过减少伤口中的自由基,为细胞分裂和迁移提供一个天然的支架,以及
增强伤口的血管生成。另一个问题是无法在术后实时监测伤口
病人离开医院,导致手指或肢体截肢。我们将通过开发
一种无线系统,可以实时监测伤口的温度和pH值,参数已经被
被证明是感染的指标。因此,这项建议的总体目标是发展一种形态--
符合抗氧化剂的敷料,暴露在体温下会转化为凝胶
促进糖尿病创面的新组织形成和涉及组织的反馈系统
符合要求的传感器,用于监测细菌感染和/或愈合不足。为了实现这一目标,我们有
开发了一种新型的高分子-聚柠檬酸乙二醇酯-N-异丙基丙烯酰胺-
结合了层粘连蛋白衍生的多肽。这种材料被称为PPCN-A5G81,支持组织再生
并且可以符合伤口的独特形状和深度。至于伤口的无线监测,我们
率先开发出灵活的、可伸展的电子传感器,可以与人体皮肤或
植入体内,用于持续、非侵入性的健康监测和疾病治疗。我们假设
1)将固定化的Cu2+加入PPCN-A5G81中,可以显著地赋予血管诱导特性
提高PPCN-A5G81‘S修复糖尿病小鼠全层真皮创面正常愈合率的能力
和猪模型;2)符合标准的温度和pH传感器是安全的,可以远程提供实时
关于糖尿病动物皮肤伤口的血液灌流和感染的信息。的具体目标
该方案旨在:1)制备一种基于PPCN的具有血管诱导、皮肤传导、
和皮肤诱导特性,并研究其对糖尿病全层创面愈合的安全性和有效性
患有代谢综合征的小鼠和糖尿病猪;以及2)制作和表征遥测伤口反馈
能够测量感染和非感染糖尿病患者温度和pH的组织整合传感器
皮肤上的伤口。这项研究的结果将有助于开发创新的临床产品,
降低截肢率,改善患者预后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guillermo Antonio Ameer其他文献
Guillermo Antonio Ameer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guillermo Antonio Ameer', 18)}}的其他基金
Regenerative Engineering Training Program (RE-Training)
再生工程培训计划(RE-Training)
- 批准号:
10641321 - 财政年份:2021
- 资助金额:
$ 64.9万 - 项目类别:
Telemetric Regenerative Bandage for Accelerating Wound Healing
用于加速伤口愈合的遥测再生绷带
- 批准号:
10663343 - 财政年份:2021
- 资助金额:
$ 64.9万 - 项目类别:
Regenerative Engineering Training Program (RE-Training)
再生工程培训计划(RE-Training)
- 批准号:
10206938 - 财政年份:2021
- 资助金额:
$ 64.9万 - 项目类别:
Regenerative Engineering Training Program (RE-Training)
再生工程培训计划(RE-Training)
- 批准号:
10424463 - 财政年份:2021
- 资助金额:
$ 64.9万 - 项目类别:
Regenerative Engineering Training Program (RE-Training)
再生工程培训计划(RE-Training)
- 批准号:
10689787 - 财政年份:2021
- 资助金额:
$ 64.9万 - 项目类别:
Low-Profile 3D-Printed Radiopaque Bioresorbable Vascular Scaffolds
薄型 3D 打印不透射线生物可吸收血管支架
- 批准号:
10093122 - 财政年份:2019
- 资助金额:
$ 64.9万 - 项目类别:
Developing a SMART scaffold for bladder augmentation
开发用于膀胱扩张的 SMART 支架
- 批准号:
10429930 - 财政年份:2019
- 资助金额:
$ 64.9万 - 项目类别:
Low-Profile 3D-Printed Radiopaque Bioresorbable Vascular Scaffolds
薄型 3D 打印不透射线生物可吸收血管支架
- 批准号:
10329908 - 财政年份:2019
- 资助金额:
$ 64.9万 - 项目类别:
Transarterial Immunomodulatory Embolization: A novel approach to cancer therapy
经动脉免疫调节栓塞:癌症治疗的新方法
- 批准号:
9555090 - 财政年份:2016
- 资助金额:
$ 64.9万 - 项目类别:
Preclinical Investigation of a Bioengineered Vascular Graft
生物工程血管移植物的临床前研究
- 批准号:
8897878 - 财政年份:2013
- 资助金额:
$ 64.9万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 64.9万 - 项目类别:
Research Grant














{{item.name}}会员




